| JXSS2500085 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSS2500081 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500090 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500080 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JTS2500009 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products | Disposable Import Drug Application | 2025-01-25 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500094 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSS2500086 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSS2500084 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSS2500074 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500091 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500077 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JTS2500008 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products | Disposable Import Drug Application | 2025-01-25 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500095 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSS2500078 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500079 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500088 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500075 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSS2500087 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JXSS2500072 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-07 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSS2500089 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products(2.1) | Import Drug Application | 2025-06-12 | | BSP Pharmaceuticals SpA;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
